Allogene Therapeutics, Inc.

NASDAQ:ALLO

2.91 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Omzet 00.0220.0210.0430.0440.0520.0470.0490.0860.0610.0510.0490.04438.3450000000000000
Kosten van de omzet 3.6443.55554.6613.5723.7933.7143.3084.4134.84960.1564.24258.722.3513.92552.22851.42147.2960000000000
Brutowinst -3.644-3.533-54.64-3.529-3.749-3.662-3.261-4.364-4.763-60.095-4.191-58.671-2.30734.42-52.228-51.421-47.2960000000000
Brutowinstmarge 0-160.591-2,601.905-82.07-85.205-70.423-69.383-89.061-55.384-985.164-82.176-1,197.367-52.4320.8980000000000000
Onderzoek- en ontwikkelingskosten 46.71148.70454.66145.97762.03880.23875.41963.64157.17160.15653.98358.7252.2955.18352.22851.42147.29642.04249.36339.99531.77423.40318.50310.87122.48600
Algemene en administratieve kosten 16.08717.26717.22417.04118.52418.88421.00218.89719.50919.89719.96118.99918.78316.36317.13416.61915.86215.64115.21215.01614.18713.05814.54311.31712.5262.5970
Verkoop- en marketingkosten 000000000000000000000000000
Verkoop-, algemene en administratieve kosten 16.08717.26717.22417.04118.52418.88421.00218.89719.50919.89719.96118.99918.78316.36317.13416.61915.86215.64115.21215.01614.18713.05814.54311.31712.5262.5970.002
Overige kosten 0.085-0.929-10.348-4.545-1.249-1.693-1.23-1.6611.492-0.35-1.161-0.909-0.531-0.325-0.766-0.162-0.156-0.058-0.268000-1.796-19.415000
Bedrijfskosten 62.79865.97171.88563.01880.56299.12296.42182.53876.6880.05373.94477.71971.07371.54669.36268.0463.15857.68364.57555.01145.96136.46133.04622.187135.0122.5970.002
Bedrijfsresultaat -66.442-69.504-71.864-62.975-80.518-99.07-96.374-82.489-76.594-79.992-73.893-77.67-71.029-33.201-69.362-68.04-63.158-57.683-64.575-55.011-45.961-36.461-33.046-22.187-135.012-2.597-0.002
Bedrijfsresultaat ratio 0-3,159.273-3,422.095-1,464.535-1,829.955-1,905.192-2,050.511-1,683.449-890.628-1,311.344-1,448.882-1,585.102-1,614.295-0.8660000000000000
Totaal overige inkomsten en kosten netto 0.0844.504-13.914-4.545-1.2490.3661.527-0.6591.8070.142-1.161-0.909-0.531-0.325-0.766-0.162-0.156-0.058-0.2684.3094.5594.825-1.796-19.4150.1100
Inkomen voor belasting -66.358-65-85.778-61.315-77.989-98.704-94.847-83.148-74.787-79.85-74.868-78.186-70.936-33.015-68.57-66.197-60.974-54.48-61.185-50.702-41.402-31.636-30.626-43.497-134.902-2.597-0.002
Inkomen voor belasting ratio 0-2,954.545-4,084.667-1,425.93-1,772.477-1,898.154-2,018.021-1,696.898-869.616-1,309.016-1,468-1,595.633-1,612.182-0.8610000000000000
Belastingkosten -03.512-0.065-6.205-3.778-0.366-1.527-1.002-0.315-0.142-4.428-0.393-0.624-0.511-3.402-3.815-2.34-3.261-0.1550.033-0.159-0.05-0.117-16.0570-2.5970
Nettowinst -66.358-65-85.778-61.315-77.989-98.338-93.32-82.146-74.472-79.708-74.868-78.186-70.936-33.015-68.57-66.197-60.974-54.48-61.03-50.735-41.243-31.586-30.509-43.497-134.902-2.597-0.002
Nettowinstmarge 0-2,954.545-4,084.667-1,425.93-1,772.477-1,891.115-1,985.532-1,676.449-865.953-1,306.689-1,468-1,595.633-1,612.182-0.8610000000000000
WPA (Winst Per Aandeel) -0.35-0.38-0.51-0.37-0.53-0.68-0.65-0.57-0.52-0.56-0.54-0.57-0.53-0.25-0.53-0.52-0.53-0.5-0.58-0.5-0.41-0.32-0.37-0.38-1.19-0.0590
Verwaterde WPA -0.35-0.38-0.51-0.37-0.53-0.68-0.65-0.57-0.52-0.56-0.54-0.57-0.53-0.25-0.53-0.52-0.53-0.5-0.58-0.5-0.41-0.32-0.37-0.38-1.19-0.0590
EBITDA -62.798-65.949-68.452-59.403-76.875-99.07-96.374-78.629-72.919-76.3-73.893-75.34-69.065-31.283-69.362-68.04-61.27-55.639-61.185-49.374-45.961-35.766-30.626-39.636-134.562-2.597-0.002
EBITDA ratio 0-2,997.682-3,259.619-1,381.465-1,747.159-1,905.192-2,050.511-1,604.673-847.895-1,250.82-1,448.882-1,537.551-1,569.659-0.8160000000000000